Cited by 154Prenatal Screening and DiagnosticsAssisted Reproductive Technology and Twin PregnancyMaternal and Perinatal Health Interventions

Potential diagnostic consequences of applying non-invasive prenatal testing: Population-based study from a country with existing first-trimester screening

Petersen, O. B., Vogel, I., Ekelund, C., Hyett, J., Tabor, A., the Danish Fetal Medicine Study Group, the Danish Clinical Genetics Study Group·2014·Ultrasound in Obstetrics & Gynecology

Abstract

Objectives: Targeted non‐invasive prenatal testing ( NIPT ) tests for trisomies 21, 18 and 13 and sex chromosome aneuploidies and could be an alternative to traditional karyotyping. The aim of this study was to determine the risk of missing other abnormal karyotypes of probable phenotypic significance by NIPT . Methods: This was a retrospective population‐based analysis of all singleton pregnancies booked for combined first‐trimester screening ( cFTS ) in Denmark over a 4‐year period. Data concerning maternal demographics, cFTS and prenatal or postnatal karyotypes were collected from the Danish Fetal Medicine database. Karyotypes were classified according to whether the chromosomal anomaly would have been detected by NIPT and whether it was likely to affect phenotype . Results: cFTS was completed in 193 638 pregnancies. 10 205 (5.3%) had cytogenetic or molecular analysis performed. Of these, 1122 (11.0%) had an abnormal karyotype, of which 262 (23.4%) would have been missed by NIPT , but would probably have been clinically significant. The prevalence of such ‘atypical abnormal karyotypes’ was increased in women above 45 years of age, in pregnancies with increased nuchal translucency ( NT ) thickness (≥ 3.5 mm), with abnormal levels of free β‐human chorionic gonadotropin (< 0.2 or ≥ 5.0 multiples of the median ( MoM )) or pregnancy‐associated plasma protein‐A < 0.2 MoM . One or more of these factors was present in 3% of women, and the prevalence of atypical abnormal karyotypes in this high‐risk cohort was 1.6% . Conclusions: A significant proportion of karyotypic abnormalities will be missed by targeted NIPT . Women of advanced maternal age, or with increased fetal NT or abnormal biochemistry, have a higher risk of having a fetus affected by an atypical abnormal karyotype and need to be counseled accordingly when considering NIPT . Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd

Integrity signals

Registry

Crossref · 10.1002/uog.13270

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cases with PAPP-A < 0.2 MoM, the prevalence of atypical abnormal karyotype was 4.17 (95% CI: 3.07-5.65).

    “Moreover, in cases with PAPP-A < 0.2 MoM, the prevalence of atypical abnormal karyotype was 4.17 (95% CI: 3.07–5.65)”
  • For free β-hCG < 0.2 MoM the relevant prevalence was 7-times higher (95% CI: 4.39-11.14).

    “while for free β-hCG < 0.2 MoM the relevant prevalence was 7-times higher (95% CI: 4.39–11.14) [86].”

Cited by

Sorted by citations

Authors
Petersen, O. B., Vogel, I., Ekelund, C., Hyett, J., Tabor, A., the Danish Fetal Medicine Study Group, & the Danish Clinical Genetics Study Group
Affiliations
  • Aarhus University Hospital (DK)
  • Copenhagen University Hospital (DK)
  • Royal Prince Alfred Hospital (AU)
Corresponding author
Petersen, O. B.
Venue
Ultrasound in Obstetrics & Gynecology
Publisher
Wiley
Published
2014-02-25
Volume
43
Issue
3
Pages
265-271
ISSN
  • 0960-7692 (ISSN-L)
  • 1469-0705
OpenAlex
W1583054954
Cited by
154
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 47 · 2017: 16 · 2016: 17 · 2015: 17 · 2014: 7
FWCI
12.76
Type
journal article
Language
en
Open access
closed
Locations
  • Ultrasound in Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
  • Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
Keywords
non-invasive prenatal testing, chromosomal abnormalities, first-trimester screening, missed diagnosis, advanced maternal age, nuchal translucency, free beta-hCG, PAPP-A, fetal karyotyping, prenatal diagnosis
MeSH terms
Adult, Denmark, Female, Humans, Infant, Newborn, Maternal Age, Pregnancy, Pregnancy Trimester, First, Pregnancy-Associated Plasma Protein-A, Prenatal Diagnosis, Retrospective Studies, Risk Factors, Biomarkers, Practice Guidelines as Topic, Chorionic Gonadotropin, beta Subunit, Human, Chromosome Disorders, Nuchal Translucency Measurement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review